ADVANCEMENTS IN STEM CELL THERAPY FOR ALZHEIMER’S DISEASE
Keywords:
Stem Cell Therapy, Alzheimer’s, BM-MSCs, hUC-MSCs, iPSCs, ESCs, Cognitive Decline, Memory LossAbstract
The advancement of stem cell technologies has generated significant interest in their potential application for treating neurodegenerative diseases such as Alzheimer’s disease (AD). This review evaluates various stem cell sources and delivery methods, focusing on bone marrow-derived mesenchymal stem cells (BM-MSCs) and human umbilical cord-derived mesenchymal stem cells (hUC-MSCs). BM-MSCs are notable for their ability to modulate microglial activation, secrete neuroprotective factors, and reduce neuronal apoptosis, although challenges persist in precise targeting and potential embolism risks. In contrast, hUC-MSCs exhibit lower immunogenicity and demonstrate enhanced efficacy in increasing neuroprotective proteins and antioxidants, thus supporting neuronal survival and reducing oxidative stress. Innovative delivery methods, including magnetic targeted cellular delivery (MTCD) and intranasal administration, have been developed to enhance the precision of stem cell localization and distribution. These techniques improve the targeting of therapeutic cells to affected brain regions and facilitate the clearance of amyloid-beta plaques. Despite the progress in stem cell-based therapies, further research is needed to address delivery challenges and optimize therapeutic outcomes. The continued exploration of these technologies and methodologies will be crucial in advancing treatment strategies for AD and related neurodegenerative disorders.
References
I. Bhatti JS, Khullar N, Mishra J, Kaur S, Sehrawat A, Sharma E, Bhatti GK, Selman A, Reddy PH. Stem cells in the treatment of Alzheimer's disease - Promises and pitfalls. Biochim Biophys Acta Mol Basis Dis. 2023 Aug;1869(6):166712. doi: 10.1016/j.bbadis.2023.166712. Epub 2023 Apr 6. PMID: 37030521.
II. Bhatti JS, Khullar N, Mishra J, Kaur S, Sehrawat A, Sharma E, Bhatti GK, Selman A, Reddy PH. Stem cells in the treatment of Alzheimer's disease - Promises and pitfalls. Biochim Biophys Acta Mol Basis Dis. 2023 Aug;1869(6):166712. doi: 10.1016/j.bbadis.2023.166712. Epub 2023 Apr 6. PMID: 37030521.
III. Young HE, Speight MO. Alzheimer’s Disease Treated with Autologous and Allogeneic Telomerase-Positive Stem Cells. Stem Cells Regen Med. 2021; 5(1): 1-17.
IV. Bhatti JS, Khullar N, Mishra J, Kaur S, Sehrawat A, Sharma E, Bhatti GK, Selman A, Reddy PH. Stem cells in the treatment of Alzheimer's disease - Promises and pitfalls. Biochim Biophys Acta Mol Basis Dis. 2023 Aug;1869(6):166712. doi: 10.1016/j.bbadis.2023.166712. Epub 2023 Apr 6. PMID: 37030521.
V. Bhatti JS, Khullar N, Mishra J, Kaur S, Sehrawat A, Sharma E, Bhatti GK, Selman A, Reddy PH. Stem cells in the treatment of Alzheimer's disease - Promises and pitfalls. Biochim Biophys Acta Mol Basis Dis. 2023 Aug;1869(6):166712. doi: 10.1016/j.bbadis.2023.166712. Epub 2023 Apr 6. PMID: 37030521.
VI. Bhatti JS, Khullar N, Mishra J, Kaur S, Sehrawat A, Sharma E, Bhatti GK, Selman A, Reddy PH. Stem cells in the treatment of Alzheimer's disease - Promises and pitfalls. Biochim Biophys Acta Mol Basis Dis. 2023 Aug;1869(6):166712. doi: 10.1016/j.bbadis.2023.166712. Epub 2023 Apr 6. PMID: 37030521.
VII. Bhatti JS, Khullar N, Mishra J, Kaur S, Sehrawat A, Sharma E, Bhatti GK, Selman A, Reddy PH. Stem cells in the treatment of Alzheimer's disease - Promises and pitfalls. Biochim Biophys Acta Mol Basis Dis. 2023 Aug;1869(6):166712. doi: 10.1016/j.bbadis.2023.166712. Epub 2023 Apr 6. PMID: 37030521.
VIII. Bhatti JS, Khullar N, Mishra J, Kaur S, Sehrawat A, Sharma E, Bhatti GK, Selman A, Reddy PH. Stem cells in the treatment of Alzheimer's disease - Promises and pitfalls. Biochim Biophys Acta Mol Basis Dis. 2023 Aug;1869(6):166712. doi: 10.1016/j.bbadis.2023.166712. Epub 2023 Apr 6. PMID: 37030521.
IX. Blurton-Jones, M., & LaFerla, F. M. (2006). Pathways by which Aβ facilitates tau pathology. Current Alzheimer Research, 3(5), 437-448.
X. Blurton-Jones, M., & LaFerla, F. M. (2006). Pathways by which Aβ facilitates tau pathology. Current Alzheimer Research, 3(5), 437-448.
XI. Bhatti JS, Khullar N, Mishra J, Kaur S, Sehrawat A, Sharma E, Bhatti GK, Selman A, Reddy PH. Stem cells in the treatment of Alzheimer's disease - Promises and pitfalls. Biochim Biophys Acta Mol Basis Dis. 2023 Aug;1869(6):166712. doi: 10.1016/j.bbadis.2023.166712. Epub 2023 Apr 6. PMID: 37030521.
XII. Bhatti JS, Khullar N, Mishra J, Kaur S, Sehrawat A, Sharma E, Bhatti GK, Selman A, Reddy PH. Stem cells in the treatment of Alzheimer's disease - Promises and pitfalls. Biochim Biophys Acta Mol Basis Dis. 2023 Aug;1869(6):166712. doi: 10.1016/j.bbadis.2023.166712. Epub 2023 Apr 6. PMID: 37030521.
XIII. Bhatti JS, Khullar N, Mishra J, Kaur S, Sehrawat A, Sharma E, Bhatti GK, Selman A, Reddy PH. Stem cells in the treatment of Alzheimer's disease - Promises and pitfalls. Biochim Biophys Acta Mol Basis Dis. 2023 Aug;1869(6):166712. doi: 10.1016/j.bbadis.2023.166712. Epub 2023 Apr 6. PMID: 37030521.
XIV. Bhatti JS, Khullar N, Mishra J, Kaur S, Sehrawat A, Sharma E, Bhatti GK, Selman A, Reddy PH. Stem cells in the treatment of Alzheimer's disease - Promises and pitfalls. Biochim Biophys Acta Mol Basis Dis. 2023 Aug;1869(6):166712. doi: 10.1016/j.bbadis.2023.166712. Epub 2023 Apr 6. PMID: 37030521.
XV. Bhatti JS, Khullar N, Mishra J, Kaur S, Sehrawat A, Sharma E, Bhatti GK, Selman A, Reddy PH. Stem cells in the treatment of Alzheimer's disease - Promises and pitfalls. Biochim Biophys Acta Mol Basis Dis. 2023 Aug;1869(6):166712. doi: 10.1016/j.bbadis.2023.166712. Epub 2023 Apr 6. PMID: 37030521.
XVI. Hampel, H., Hardy, J., Blennow, K., Chen, C., Perry, G., Kim, S. H., ... & Vergallo, A. (2021). The amyloid-β pathway in Alzheimer’s disease. Molecular psychiatry, 26(10), 5481-5503.
XVII. Si, Z., & Wang, X. (2021). Stem cell therapies in Alzheimer's disease: applications for disease modeling. Journal of Pharmacology and Experimental Therapeutics, 377(2), 207-217.
XVIII. Si, Z., & Wang, X. (2021). Stem cell therapies in Alzheimer's disease: applications for disease modeling. Journal of Pharmacology and Experimental Therapeutics, 377(2), 207-217.
XIX. Bhatti JS, Khullar N, Mishra J, Kaur S, Sehrawat A, Sharma E, Bhatti GK, Selman A, Reddy PH. Stem cells in the treatment of Alzheimer's disease - Promises and pitfalls. Biochim Biophys Acta Mol Basis Dis. 2023 Aug;1869(6):166712. doi: 10.1016/j.bbadis.2023.166712. Epub 2023 Apr 6. PMID: 37030521.
XX. Bhatti JS, Khullar N, Mishra J, Kaur S, Sehrawat A, Sharma E, Bhatti GK, Selman A, Reddy PH. Stem cells in the treatment of Alzheimer's disease - Promises and pitfalls. Biochim Biophys Acta Mol Basis Dis. 2023 Aug;1869(6):166712. doi: 10.1016/j.bbadis.2023.166712. Epub 2023 Apr 6. PMID: 37030521.
XXI. Bhatti JS, Khullar N, Mishra J, Kaur S, Sehrawat A, Sharma E, Bhatti GK, Selman A, Reddy PH. Stem cells in the treatment of Alzheimer's disease - Promises and pitfalls. Biochim Biophys Acta Mol Basis Dis. 2023 Aug;1869(6):166712. doi: 10.1016/j.bbadis.2023.166712. Epub 2023 Apr 6. PMID: 37030521.
XXII. Yu, S., Hei, Y., & Liu, W. (2018). Upregulation of seladin‑1 and nestin expression in bone marrow mesenchymal stem cell transplantation via the ERK1/2 and PI3K/Akt signaling pathways in an Alzheimer's disease model. Oncology Letters, 15(5), 7443-7449.Chen, J., Li, Y., Zhang, R., Katakowski, M., Gautam, S. C., Xu, Y., ... & Chopp, M. (2004). Combination therapy of stroke in rats with a nitric oxide donor and human bone marrow stromal cells enhances angiogenesis and neurogenesis. Brain research, 1005(1-2), 21-28.
XXIII. Chen, J., Li, Y., Zhang, R., Katakowski, M., Gautam, S. C., Xu, Y., ... & Chopp, M. (2004). Combination therapy of stroke in rats with a nitric oxide donor and human bone marrow stromal cells enhances angiogenesis and neurogenesis. Brain research, 1005(1-2), 21-28.
XXIV. Shin, J. W., Lee, J. K., Lee, J. E., Min, W. K., Schuchman, E. H., Jin, H. K., & Bae, J. S. (2011). Combined effects of hematopoietic progenitor cell mobilization from bone marrow by granulocyte colony stimulating factor and AMD3100 and chemotaxis into the brain using stromal cell‐derived factor‐1α in an Alzheimer's disease mouse model. Stem cells, 29(7), 1075-1089.
XXV. Cui, Y., Ma, S., Zhang, C., Cao, W., Liu, M., Li, D., ... & Guan, F. (2017). Human umbilical cord mesenchymal stem cells transplantation improves cognitive function in Alzheimer’s disease mice by decreasing oxidative stress and promoting hippocampal neurogenesis. Behavioural Brain Research, 320, 291-301.
XXVI. Gang, E. J., Hong, S. H., Jeong, J. A., Hwang, S. H., Kim, S. W., Yang, I. H., ... & Kim, H. (2004). In vitro mesengenic potential of human umbilical cord blood-derived mesenchymal stem cells. Biochemical and biophysical research communications, 321(1), 102-108.
XXVII. Ma, S., Zhou, X., Wang, Y., Li, Z., Wang, Y., Shi, J., & Guan, F. (2022). MG53 protein rejuvenates hUC-MSCs and facilitates their therapeutic effects in AD mice by activating Nrf2 signaling pathway. Redox Biology, 53, 102325.
XXVIII. Hour, F. Q., Moghadam, A. J., Shakeri-Zadeh, A., Bakhtiyari, M., Shabani, R., & Mehdizadeh, M. (2020). Magnetic targeted delivery of the SPIONs-labeled mesenchymal stem cells derived from human Wharton's jelly in Alzheimer's rat models. Journal of Controlled Release, 321, 430-441.
XXIX. Hour, F. Q., Moghadam, A. J., Shakeri-Zadeh, A., Bakhtiyari, M., Shabani, R., & Mehdizadeh, M. (2020). Magnetic targeted delivery of the SPIONs-labeled mesenchymal stem cells derived from human Wharton's jelly in Alzheimer's rat models. Journal of Controlled Release, 321, 430-441.
XXX. Li, L., Jiang, Q., Ding, G., Zhang, L., Zhang, Z. G., Li, Q., ... & Chopp, M. (2010). Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study. Journal of Cerebral Blood Flow & Metabolism, 30(3), 653-662.
XXXI. Li, L., Jiang, Q., Ding, G., Zhang, L., Zhang, Z. G., Li, Q., ... & Chopp, M. (2010). Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study. Journal of Cerebral Blood Flow & Metabolism, 30(3), 653-662
XXXII. Advancements in Stem Cell Therapy for Alzeheimer’s Disease © 2024 by Christa Kudaverdian is licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 International Educational Journal of Science and Engineering
This work is licensed under a Creative Commons Attribution 4.0 International License.
